Cyberonics Inc (NASDAQ:CYBX)
During the Trading Day
| 48.12 |  -1.39 / -2.81% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 48.12 |  0.00 / 0.00% |
Volume: 2,000.00 |
Latest CYBX News | Press Releases
| CYBX January 2014 Options Begin Trading May 20 / TheStreet.com |
Today’s Trading
| Previous close | 49.51 |
| Today’s open | 49.64 |
| Day’s range | 47.74 - 49.88 |
| Volume | 227,963 |
| Average volume (3 months) | 367,158 |
| Market cap | $1.4B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -21.95% |
| Earnings growth (this year) | +33.07% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +14.72% |
| P/E ratio | 29.7 |
| Price/Sales | 4.91 |
| Price/Book | 7.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HTWRHeartWare Internatio... | -2.24 | -2.36% |
| PCRXPacira Pharmaceutica... | +0.24 | +0.83% |
| CMNCantel Medical Corp | -0.73 | -2.11% |
| THORThoratec Corp | -0.55 | -1.74% |
Data as of 4:03pm ET, 05/22/2013
Financials
| Next reporting date | June 5, 2013 |
| EPS forecast (this quarter) | $0.42 |
| Annual revenue (last year) | $218.5M |
| Annual profit (last year) | $36.1M |
| Net profit margin | 16.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Daniel Jeffrey Moore, MBA |
Vice President- Operations Randal L. Simpson |
Corporate headquarters Houston, Texas |
Forecasts
